DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF
about
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphomaThe current status of targeting BAFF/BLyS for autoimmune diseasesExploring BAFF: its expression, receptors and contribution to the immunopathogenesis of Sjögren's syndromeNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesA therapeutic role for BLyS antagonistsAirway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism.The strength of the antibody response to the nematode Ascaris lumbricoides inversely correlates with levels of B-Cell Activating Factor (BAFF).BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus.B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndromeDifferential induction of plasma cells by isoforms of human TACI.Molecular mechanisms guiding late stages of B-cell development.Regulation of the B cell receptor repertoire and self-reactivity by BAFFThe BLyS family of ligands and receptors: an archetype for niche-specific homeostatic regulation.Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases.Role of BAFF and APRIL in human B-cell chronic lymphocytic leukaemia.Expression of BAFF and BR3 in patients with systemic lupus erythematosus.The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.Manipulating B cell homeostasis: a key component in the advancement of targeted strategiesThe BLyS family: toward a molecular understanding of B cell homeostasis.Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma.Targeting the splicing of mRNA in autoimmune diseases: BAFF inhibition in Sjögren's syndrome as a proof of conceptBAFF inhibition: a new class of drugs for the treatment of autoimmunity.Therapeutic targeting of the BAFF/APRIL axis in systemic lupus erythematosus.Development of a Novel BAFF Responsive Cell Line Suitable for Detecting Bioactive BAFF and Neutralizing Antibodies against BAFF-Pathway Inhibiting Therapeutics.Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy.Causal variants in autoimmune disease: a commentary on a recent published fine-mapping algorithm analysis in genome-wide association studies studyEffects of APRIL (TNFSF13) polymorphisms and splicing isoforms on the secretion of soluble APRIL.Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.TACI Isoforms Regulate Ligand Binding and Receptor Function
P2860
Q24646563-0AD07098-1D39-45D5-8DE4-6074B17CB6C4Q24796930-AEE42B61-CE3B-46E7-888F-8D4E52C2862AQ26770648-77B1AD4D-0A61-412E-B862-0B9F3A8DA05BQ27024640-09A97BA7-D6C4-4D0C-8DC7-816465023360Q28269809-2404E8B3-1837-46F1-A41C-9DB6F38F2F3CQ33584291-BB98CA48-5CC1-403B-923F-C326E994D02EQ33792424-86E6C0F4-D3FD-4A02-A43E-D1FCBD70526EQ34245983-857D55E2-CB5E-4891-B143-1AF6C234F5D7Q34895937-76DF7411-4F71-44D2-AC64-3534C5DB820FQ34896464-EC1B46FF-936C-4B57-BECE-4D4783F2B7B2Q35171263-EC39BB55-7736-4E43-8D0B-9CEA3324C673Q35666660-1F6C72DB-79FB-4707-BD9D-BF520FCD10FFQ35686885-CC791FAC-9136-4E96-9AD6-2BB275369205Q35951839-8887123D-53F4-492E-A129-BE25C13B17C6Q36005239-D5FEE922-9996-4FB6-8DB1-6E23F6117474Q36530420-46B72BC8-C907-4758-B187-4052F2E71AFCQ36607723-93416B28-36CB-438C-9C7A-87B16162F647Q37170754-064FC9DB-3F0F-4A8E-A772-478F99D648E7Q37177128-C34D805A-4DC1-49DD-B99E-B05CB6FFB7ACQ37335169-B0BBAC8F-682F-46DA-85D6-61E4C12408D8Q37345560-B26412EE-AFC3-4C53-AE10-00D841969B6BQ37696041-261032F6-807F-4E63-B042-05FDE5B6BDB3Q37844764-72E1F1C0-8950-448A-96DA-2EECD00C6510Q38187489-E30A50E5-8270-45E3-AFD9-906BCA05C320Q38673541-A24BCE43-D7D3-4486-B9C5-E0E0441223A3Q40272900-B280F63C-4954-4E1F-ADE5-9C055E18E37DQ42361716-619C5B52-A9E5-439E-AD56-A0694C0423FFQ43748232-6E41FA2A-FAD3-468B-A3F0-471BD2795557Q45285288-AD884679-5523-46BB-8F44-7DBD18F957DEQ58586489-20FB1049-F4C4-4D7B-9392-9BC8112D28F7
P2860
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFF
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@ast
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en-gb
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@nl
type
label
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@ast
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en-gb
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@nl
prefLabel
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@ast
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en-gb
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@nl
P2093
P2860
P3181
P356
P1476
DeltaBAFF, an alternate splice ...... B cell survival cytokine, BAFF
@en
P2093
Amanda L Gavin
Carl F Ware
Djemel Aït-Azzouzene
P2860
P304
38220-38228
P3181
P356
10.1074/JBC.M306852200
P407
P50
P577
2003-07-16T00:00:00Z